Neurodegenerative disease and iron storage in the brain

被引:95
作者
Thomas, M
Jankovic, J
机构
[1] Baylor Coll Med, Dept Neurol, Parkinsons Dis Ctr & Movement Disorders Clin, Houston, TX 77030 USA
[2] NINDS, Expt Therapeut Branch, Clin Pharmacol Sect, NIH, Bethesda, MD USA
关键词
Hallervorden-Spatz; iron in the brain; neurodegeneration; neuroferritinopathy; parkinsonism;
D O I
10.1097/01.wco.0000137534.61244.d1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose of review Iron is very important for normal regulation of various metabolic pathways. Neurons store iron in the form of ferrous ion or neuromelanin. In specific disorders the axonal transport of iron is impaired, leading to iron deposition which in the presence of reactive oxygen species results in neurodegeneration. Recent findings Recent developments in genetics, including the finding of mutations in the pantothenate kinase gene and ferritin light chain gene, have demonstrated a direct relationship between the presence of a mutation in the iron-regulatory pathways and iron deposition in the brain resulting in neurodegeneration. These two disorders now add to our understanding of the mechanism of disease due to dysfunction of iron-regulatory pathways. In addition to these disorders there may be several other mutations of iron-regulatory genes or related genes that are yet to be found. The animal models of disease have also added value to this area. Summary In this review we provide a summary of recent developments in the field of movement disorders with abnormalities in iron transport, and the current evidence in neurodegenerative disorders such as Parkinson's disease.
引用
收藏
页码:437 / 442
页数:6
相关论文
共 50 条
  • [1] Friedreich's ataxia:: Idebenone treatment in early stage patients
    Artuch, R
    Aracil, A
    Mas, A
    Colomé, C
    Rissech, M
    Monrós, E
    Pineda, M
    [J]. NEUROPEDIATRICS, 2002, 33 (04) : 190 - 193
  • [2] Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia
    Becker, E
    Richardson, DR
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2001, 33 (01) : 1 - 10
  • [3] Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats
    Ben Shachar, D
    Kahana, N
    Kampel, V
    Warshawsky, A
    Youdim, MBH
    [J]. NEUROPHARMACOLOGY, 2004, 46 (02) : 254 - 263
  • [4] Iron regulatory proteins in pathobiology
    Cairo, G
    Pietrangelo, A
    [J]. BIOCHEMICAL JOURNAL, 2000, 352 : 241 - 250
  • [5] Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
    Campuzano, V
    Montermini, L
    Lutz, Y
    Cova, L
    Hindelang, C
    Jiralerspong, S
    Trottier, Y
    Kish, SJ
    Faucheux, B
    Trouillas, P
    Authier, FJ
    Durr, A
    Mandel, JL
    Vescovi, A
    Pandolfo, M
    Koenig, M
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (11) : 1771 - 1780
  • [6] HARP syndrome is allelic with pantothenate kinase-associated neurodegeneration
    Ching, KHL
    Westaway, SK
    Gitschier, J
    Higgins, JJ
    Hayflick, SJ
    [J]. NEUROLOGY, 2002, 58 (11) : 1673 - 1674
  • [7] Neuroferritinopathy in a French family with late onset dominant dystonia -: art. no. e69
    Chinnery, PF
    Curtis, ARJ
    Fey, C
    Coulthard, A
    Crompton, D
    Curtis, A
    Lombès, A
    Burn, J
    [J]. JOURNAL OF MEDICAL GENETICS, 2003, 40 (05) : e69
  • [8] Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome
    Connor, JR
    Boyer, PJ
    Menzies, SL
    Dellinger, B
    Allen, RP
    Ondo, WG
    Earley, CJ
    [J]. NEUROLOGY, 2003, 61 (03) : 304 - 309
  • [9] Iron and iron management proteins in neurobiology
    Connor, JR
    Menzies, SL
    Burdo, JR
    Boyer, PJ
    [J]. PEDIATRIC NEUROLOGY, 2001, 25 (02) : 118 - 129
  • [10] COSEE M, 1999, ANN NEUROL, V45, P673